PROBUPREN
Pharmaceuticals, namely, implantable drug delivery system comprised primarily of sustained release drugs in the treatment of cancer, central nervous system disorders, hematological disorders, endocrine disorders, metabolic disorders, inflammatory disorders, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular disorders, circulatory system disease, intestinal disorders, bone disease, autoimmune disorders and other disorders of the immune ...
Abandoned · July 6, 2001 · 76281258 ·